Acceleron Reports First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Acceleron Reports First Quarter 2021 Financial Results

Acceleron Pharma (XLRN) Tops Q1 EPS by 4c, Revenues Miss

May 6, 2021 4:04 PM EDT

Acceleron Pharma (NASDAQ: XLRN) reported Q1 EPS of ($0.77), $0.04 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $24.76 million versus the consensus estimate of $28.89 million.

Acceleron made significant operational progress during the first quarter, said Habib Dable, President and Chief Executive Officer of Acceleron. With the STELLAR Phase 3 trial already enrolling patients, we expect to initiate multiple mid- and late-stage clinical... More